𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rapid Improvement of Liver Function in a Patient with HIV and Hepatitis B Coinfection Treated with Lamivudine and Tenofovir

✍ Scribed by C. Lehmann; C. Wyen; G. Fätkenheuer

Book ID
107705411
Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
246 KB
Volume
34
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High frequency of lamivudine resistance
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B
✍ M.C. Mendes-Correa; J.R.R. Pinho; S. Locarnini; L. Yuen; R. Sitnik; R.A.F. Santa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract This study analyzed the genotype distribution and frequency of lamivudine (LAM) and tenofovir (TDF) resistance mutations in a group of patients co‐infected with HIV and hepatitis B virus (HBV). A cross‐sectional study of 847 patients with HIV was conducted. Patients provided blood sampl

Effect of lamivudine on morphology and f
Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B
✍ P Honkoop; R A De Man; H R Scholte; P E Zondervan; J W Van Den Berg; L H Rademak 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

Nucleoside analogues can induce mitochondrial dysfunction leading to severe clinical syndromes. Lamivudine, a new nucleoside analogue, is an active inhibitor of hepatitis B viral replication without apparent clinical toxicity. To assess subclinical mitochondrial toxicity, we studied the morphology a

Evolution of hepatitis B virus sequence
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy
✍ Kyun-Hwan Kim; Kwang-Hee Lee; Hye-Young Chang; Sang Hoon Ahn; Shuping Tong; Youn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

## Abstract Recurrent hepatitis B virus (HBV) infection after liver transplantation can be prevented by prophylactic hepatitis B immune globulin (HBIG) and lamivudine therapy. However, reinfection may still occur due to the emergence of immune escape mutants and mutants of the YMDD motif. The full